Related Experiment Videos

Nonfatal, unintentional medication exposures among young children--United States, 2001-2003

    MMWR. Morbidity and Mortality Weekly Report
    |January 18, 2006
    PubMed

    Insights

    Young children face risks from unsecured medications, leading to thousands of emergency department visits annually. Secure storage is crucial to prevent accidental pediatric medication exposures and poisonings.

    Area of Science:

    • Pediatric Safety
    • Public Health
    • Toxicology

    Background:

    • Young children are at high risk for accidental exposure to prescription and over-the-counter (OTC) medications due to improper storage.
    • Medication poisonings represent a significant public health concern for young children in the United States.

    Purpose of the Study:

    • To analyze the incidence and characteristics of unintentional medication exposures in young children treated in U.S. emergency departments.
    • To highlight the vulnerability of children aged 4 years and younger to medication access.

    Main Methods:

    • Analysis of data from the National Electronic Injury Surveillance System--All Injury Program (NEISS-AIP) for the years 2001-2003.
    • Examination of emergency department (ED) visit data for children aged 4 years and younger related to unintentional medication exposures.

    Main Results:

    • An estimated 53,517 children aged 4 years and younger were treated annually in U.S. EDs for unintentional medication exposures between 2001-2003.
    • The majority of these exposures, approximately 72%, occurred in children aged 1-2 years.
    • Children in this age group can easily access medications stored in accessible locations like purses, tables, or drawers.

    Conclusions:

    • Urgent need for parents and caregivers to implement secure medication storage practices.
    • Emphasize keeping medications out of children's reach and sight to prevent accidental ingestion.
    • Vigilance is required to prevent children's access to medications, including those in daily pill organizers.

    Related Concept Videos

    Pharmaceutical Poisoning: Potential Scenarios01:26

    Pharmaceutical Poisoning: Potential Scenarios

    Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Factors Affecting Drug Response: Overview01:21

    Factors Affecting Drug Response: Overview

    When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...